Peptide vendor shutdowns, raids and FDA warnings
Every closure, raid, FDA warning letter, lawsuit and domain change we've found that affects research peptide vendors, each dated and sourced. Latest: Oct 15, 2026. Subscribe with RSS.
- FDA warning letter: 15
- Regulatory: 9
- Closure: 6
- Raid: 4
- Lawsuit: 3
- Domain change: 1
Vendors that have shut down or gone offline
| Vendor | Status | Closure reported | What we know |
|---|---|---|---|
| PureRawz | Closed | Oct 15, 2026 | PureRawz no longer sells research chemicals. Its site now describes itself as an informational and affiliate website that doesn't sell or supply the products it features, and its peptide pages link out to other vendors. Details · Alternatives |
| Chameleon Peptides | Closed | Sep 27, 2026 | Our check on Oct 15, 2026 found this on the homepage: "Chameleon Peptides is Closed Customer archive Chameleon Peptides is…". Details · Alternatives |
| Strate Labs | Closed | Jul 28, 2026 | Community posts and a directory article report Strate Labs wound down around July 2026. Its domain stratelabs.is shows a registration date of Jul 10, 2026 although it was archived from Jul 22, 2025, so it was re-registered, and it now redirects to an unrelated store (glpeptides.is). Details · Alternatives |
| Peptide Sciences | Closed | Mar 8, 2026 | Reported closed in March 2026 by several industry newsletters and directories; the domain now serves a bot-protection page, so we could not read the site. Details · Alternatives |
| Science.bio | Closed | Feb 8, 2026 | Science.bio's homepage says it has permanently closed and discontinued research products; a community post dates the closure to Jan 27, 2026. Details · Alternatives |
| Amino Asylum | Closed | Reported shut down after a June 2025 FDA raid, per secondary sources; no FDA or DOJ release found. Details · Alternatives | |
| Ascension Peptides | Site down | Unreachable since at least Oct 14, 2026. Details · Alternatives | |
| Core Peptides | Site down | Unreachable since at least Oct 14, 2026. Details · Alternatives | |
| Dynotides | Site down | Unreachable since at least Oct 14, 2026. Details · Alternatives | |
| Eternal Peptides | Site down | The Internet Archive's last working copy of the store is dated Jun 1, 2026; its capture on Sep 20, 2026 recorded an HTTP 503 error. Unreachable since at least Oct 14, 2026. Details · Alternatives | |
| Paradigm Peptides | Closed | The owner and a co-defendant pleaded guilty on Dec 10, 2025 in the Northern District of Indiana to introducing unapproved drugs into interstate commerce; local news reports the owner was sentenced on Jul 30, 2026 to 70 months in prison. A newer, unaffiliated site using the name says the original store closed about two years ago. Details · Alternatives | |
| Peptides 4 Research | Site down | Unreachable since at least Oct 14, 2026. Details · Alternatives | |
| Soma Chems | Closed | Our check on Oct 15, 2026 found this on the homepage: "Soma Chems Our store is no longer accepting new orders. Thanks for your support! Manage Orders Or…". Details · Alternatives |
All alerts, newest first
-
Injectify says it is closing
On October 15, 2026, Injectify's homepage said the business was "closing soon" and advertised a closing-down discount. Its US store was still listing products when we checked; the notice gave no closing date.
-
PureRawz no longer sells research chemicals
By October 15, 2026, purerawz.co described itself as "an informational and affiliate website" that does "not sell or directly supply the products featured on this website". Its peptide pages now link to other vendors with a discount code instead of selling.
-
TGA takes former peptide company BioV8 and its directors to court
The TGA announced that the former company and directors behind BioV8, an Australian online peptide seller, will face court over alleged unlawful advertising of peptides. These are allegations; the court hasn't ruled.
-
Chameleon Peptides closes to new customers
Chameleon Peptides' storefront says it is closed for new purchases, with a sign-in archive left open so existing customers can view order history and lab reports. A review site dates the closure to September 27, 2026; an archived capture from September 20, 2026 shows the shop still operating.
-
FDA warning letter to TXP Innovations LLC (Tex Peptides)
FDA reviewed texpeptide.com in July 2026 and classed semaglutide, tirzepatide, retatrutide, SS-31, tesamorelin, PT-141 and bacteriostatic water products as unapproved new drugs. It cited bacteriostatic water marketed for reconstituting the products as evidence of intended human use.
-
FDA warning letter to Royal Peptides LLC
FDA reviewed royal-peptides.com in July 2026 and classed its tirzepatide, semaglutide, retatrutide, SS-31, PT-141, tesamorelin and 'BIMORELIN' products as unapproved new drugs. It said bacteriostatic water sold alongside a 'peptide guide' and 'peptide calculator' showed the products were intended for human use.
-
FDA warning letter to Peptide Partners LLC
FDA reviewed peptide.partners in July 2026 and classed its semaglutide, tirzepatide, retatrutide, SS-31, tesamorelin and bremelanotide (PT-141) products, and a bacteriostatic water 'Reconstitution Solution', as unapproved new drugs.
-
FDA warning letter to Peak Performance Peptides
FDA reviewed pppepz.com in July 2026 and classed bacteriostatic water, 'GLP-3R' (retatrutide), semaglutide, SS-31, PT-141 and tesamorelin as unapproved new drugs, rejecting 'research use only' and 'not for human consumption' labels.
-
FDA warning letter to NuScience Peptides LLC
FDA reviewed nusciencepeptides.com in July 2026 and classed products including 'GLP-1 Sema', 'GLP-2 Tirz', 'GLP-3 RT (Retatrutide)', survodutide, mazdutide, PT-141, tesamorelin and bacteriostatic water as unapproved new drugs, rejecting 'for laboratory, research, and analytical use' labels.
-
Eli Lilly sues six sellers over retatrutide
Eli Lilly announced lawsuits against Aesthetic Envy Cosmetic Centers, Astra, Legendary Peptides, Striker Pharmacy, Texas Peptides and Lone Star Peptide over sales of retatrutide, its unapproved investigational drug. Lilly alleges some sellers labeled the drug 'research use only' while selling it for human use.
-
TGA seizes peptides linked to a social media influencer
With NSW Police, the TGA executed search warrants at two New South Wales properties and seized more than $120,000 of peptide and steroid products, including retatrutide, CJC-1295 and a BPC-157 and TB-500 blend, allegedly imported, relabelled and sold online by an influencer the TGA had previously warned.
-
Paradigm Peptides owner sentenced to 70 months
The owner of Paradigm Peptides (Paradigm R.E. LLC), which sold peptides, hCG and products labeled as SARMs online, was sentenced to 5 years and 10 months in federal prison; a company employee received 1 year and 4 months. Both pleaded guilty on December 10, 2025. Investigators found that many products sold as SARMs contained testosterone.
-
Strate Labs permanently closes
By July 28, 2026, stratelabs.com showed a notice that the company had permanently closed because the regulatory landscape had shifted in ways that made it impossible to continue operating as before. The notice said pending orders would ship as scheduled.
-
FDA advisory committee backs four peptides for compounding
The FDA's Pharmacy Compounding Advisory Committee voted 8-6 with one abstention in favor of BPC-157 for compounding; trade press reported the same tally for KPV and TB-500 and 7-5 with two abstentions for MOTS-c, against the views of FDA staff scientists. The votes are non-binding, and formal rulemaking is needed before pharmacies may compound these peptides.
-
TGA puts peptide promoters and suppliers on notice
The TGA warned that suppliers and promoters of unapproved peptide products, including influencers, affiliates and online sellers, may face warning letters, infringement notices, seizures, civil penalties and, in serious cases, prosecution. It said it is working with social media and e-commerce platforms to remove unlawful advertising.
-
FDA warning letter to Wholesale Peptide
FDA reviewed wholesalepeptide.com in May 2026 and classed its Prostamax and gonadorelin products as unapproved new drugs, noting that injectable products bypass some of the body's key defences against toxins and microorganisms.
-
TGA makes unapproved peptides a compliance priority
Australia's TGA added unapproved peptide products to its compliance priority areas after increased unlawful importation, supply and advertising. It cited a joint operation with Australian Border Force and Victoria Police that seized peptides, performance and image enhancing drugs and steroids worth more than $2 million.
-
MHRA's largest seizure of unlicensed weight-loss medicines
MHRA officers raided a property near Northampton believed to be used to make and distribute unlicensed weight-loss medicines, including retatrutide and tirzepatide, as well as peptide products. They recovered about 12,000 doses of unlicensed weight-loss medicines and arrested two men on suspicion of offenses under the Human Medicines Regulations 2012.
-
FDA lists BPC-157, TB-500 and other peptides as 'nominated but withdrawn'
As of its April 22, 2026 update, the FDA's page on bulk drug substances with significant safety risks lists BPC-157, TB-500, CJC-1295, KPV, MOTS-c and other peptides under 'bulk drug substances nominated but withdrawn' (previously category 2). GHRP-2, GHRP-6 and kisspeptin-10 remain in category 2. None of these peptides is in category 1.
-
Health Canada: 'research use only' labels don't make peptides legal
Health Canada warned consumers against injectable peptides bought online and said 'For Research Use Only – Not for Human Consumption' labeling does not make products legal or exempt from regulatory requirements. It said it is working with the Canada Border Services Agency to stop unauthorized shipments.
-
Amino Asylum's domain redirects to a parking-style page
Amino Asylum is no longer trading. An archived capture from April 2, 2026 shows aminoasylum.com redirecting to ww1.aminoasylum.com, a pattern typical of domain-parking services. Widely repeated reports of a June 2025 FDA raid could not be confirmed against any FDA, Department of Justice or court record.
-
FDA warning letter to Gram Peptides
FDA reviewed grampeptides.com from January to March 2026 and found retatrutide (sold as 'GLP-1-R peptide'), tirzepatide ('GLP-2 peptide') and bacteriostatic water for injection for sale. It rejected 'Research Use Only' labels and classed the products as unapproved new drugs.
-
Peptide Sciences shuts down
By March 8, 2026, Peptide Sciences' homepage carried a notice that the company had decided to voluntarily shut down operations and discontinue the sale of its research products. The notice gave no reason.
-
MHRA raids two sites in Lincolnshire and Nottinghamshire
The MHRA announced raids on a farm near Sleaford and a home in Grantham believed to be used to make and distribute unlicensed weight-loss medicines, including retatrutide and tirzepatide, as well as peptide products. Officers seized almost 2,000 doses awaiting dispatch.
-
Science.bio permanently closes
By February 8, 2026, Science.bio's homepage said it had permanently closed; an archived capture from January 7, 2026 still shows the shop. Its current notice warns that any website, entity or individual claiming to be Science.bio or its successor is fraudulent.
-
Health Canada warns about products seized at Rize Fitness
Health Canada seized unauthorized health products from Rize Fitness in Vancouver, which also sold them online. They included injectable peptides sold under the PHX Labs name, such as semaglutide, AOD-9604, CJC-1295, epithalon and GHK-Cu.
-
MHRA dismantles an illicit weight-loss injection factory in Northampton
The MHRA's Criminal Enforcement Unit raided a Northampton warehouse it described as the UK's first illicit weight-loss medicine production facility. Officers seized more than 2,000 unlicensed retatrutide and tirzepatide pens awaiting dispatch, along with tens of thousands of empty pens and raw ingredients.
-
Health Canada warns about peptides seized from Canada Peptide
Health Canada said it seized unauthorized injectable peptide drugs from Canada Peptide, which sold them through its website. The affected products include BPC-157, CJC-1295, retatrutide and tirzepatide among dozens of others; none is authorized for sale in Canada.
-
Health Canada seizes peptides sold by Prime Research
Health Canada seized unauthorized injectable peptide drugs and bodybuilding drugs sold online by Prime Research of Sherbrooke, Quebec. At Health Canada's request, the company stopped advertising and selling the products and took down its website.
-
FDA warning letter to USApeptide.com
FDA said usapeptide.com was introducing unapproved and misbranded semaglutide and tirzepatide products into interstate commerce, and warned that drugs which circumvent regulatory safeguards may be contaminated, counterfeit, or contain varying or different ingredients.
-
FDA warning letter to Xcel Research LLC (Xcel Peptides)
FDA reviewed xcelpeptides.com in October 2024 and found retatrutide, cagrilintide, a cagrilintide and semaglutide product, mazdutide, semaglutide, survodutide and sermorelin for sale. It rejected 'For research use only' and 'Not intended for human use' labels and classed the products as unapproved new drugs.
-
FDA warning letter to Swisschems
FDA reviewed swisschems.is and the seller's Facebook and Instagram accounts in October 2024 and found semaglutide and retatrutide for sale. It said 'research chemicals only' labeling did not change its finding that the products are unapproved new drugs.
-
FDA warning letter to Summit Research Peptides
FDA reviewed summitpeptides.shop and the seller's Facebook page in October 2024 and found semaglutide, retatrutide, cagrilintide, tirzepatide and mazdutide for sale. It classed the products as unapproved new drugs.
-
FDA warning letter to Prime Vitality, Inc. (Prime Peptides)
FDA reviewed primepeptides.co and the seller's social media in October 2024 and found semaglutide and retatrutide for sale. It rejected 'research purposes only' and 'not for human consumption' labels and classed the products as unapproved new drugs.
-
Health Canada warns about peptides sold on Quadragen and Advanced Research websites
Health Canada warned consumers not to buy unauthorized injectable peptide drugs from quadragen.io and advancedresearch.bio, websites associated with Quad Inc. A July 19, 2024 update added nootropic drops and an RU-58841 topical product found among the products seized from the company.
-
FDA warning letter to US Chem Labs
FDA reviewed uschemlabs.com in October 2023 and found semaglutide, tirzepatide and thymalin offered as 'research chemicals only'. It classed the products as unapproved new drugs and misbranded drugs.
-
FDA warning letter to Synthetix Inc. (Helix Chemical Supply)
FDA reviewed helixchem.com in October 2023 and found semaglutide and tirzepatide for sale alongside health claims and dosing schedules. It said 'research use only' and 'not for human consumption' labels did not change its finding that the products are unapproved new drugs and misbranded drugs.
-
FDA warning letter to Warrior Labz SARMS
FDA reviewed warriorlabzsarms.com in May 2023 and found BPC-157 (injectable and nasal spray), TB-500 and SARMs for sale. It said 'research purpose only' and 'not for human consumption' labels did not change its finding that the products are unapproved new drugs.